GERN mentioned on another board. Put out good interim looks on a couple of phase 2 trials and surged from $200M -> $1B market cap over the past week. It's a NASDAQ company with adequate funding.
We need to get off OTC and get the funding squared away. With a little more cash on the books we will quickly be revalued at $1B+ with what we have in the pipeline. Hang in there IPIXers! Bring the deal home, Leo! We're rooting for you!
Go IPIX!
(1)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.